Grupo Supervielle S.A. (SUPV) Q2 2025 Earnings Call Transcript
Net Income ARS 13.6 billion in Q2 2025, up 62% sequentially. This increase was driven by higher net financial income and lower inflation adjustment.
Return on Equity (ROE) 6% in real terms, supported by disciplined cost management and improved net interest margin (NIM).
Client Net Financial Income Up 10%, supported by wider spreads on higher loan volumes.
Market-Related Net Financial Income Grew 15% quarter-on-quarter, benefiting from gains in the treasury portfolio.
Inflation Adjustment Decreased 34%, reflecting the lower impact in the net monetary position from declining inflation versus the prior quarter.
Net Fee Income Down 13% as banking fees were not adjusted in the quarter, though repricing is underway in the third quarter.
Expenses Up 4% as costs were seasonally lower in the prior quarter. Year-to-date, expenses declined 11% as the company simplified its structure and reduced fixed costs.
Loan Loss Provisions Rose 32%, reflecting loan growth and higher risk weighting from retail lending.
Total Loans Increased 14% sequentially and 71% year-on-year in real terms. Retail loans were up 130% year-on-year, while commercial lending was up 23% quarter-on-quarter.
Non-Performing Loan (NPL) Ratio 2.7%, in line with both historical and industry levels. Retail delinquency was 4.5%, while the NPL ratio for corporate and SME loans was 1.4%.
Provisions Rose 32% sequentially to ARS 44.5 billion, lifting net cost of risk by 70 basis points to 5.5%.
Total Funding Increased 30% year-on-year and 6% sequentially, supported by strong dollar deposit inflows and a growing contribution from corporate notes.
U.S. Dollar Deposits Up 154% year-on-year and 16% sequentially, setting a record high at $943 million.
Net Interest Margin (NIM) Expanded 160 basis points sequentially to 20.8%, supported by strong spreads in both client and market-related portfolios.
Trade with 70% Backtested Accuracy
Analyst Views on SUPV
About SUPV
About the author


Analyst Coverage Initiations: Several Wall Street analysts have initiated coverage on various companies, providing new ratings and price targets for investors to consider.
Option Care Health Inc: Raj Kumar from Stephens & Co. rated Option Care Health Inc (OPCH) as Overweight with a price target of $40, while the stock closed at $33.09.
Grupo Supervielle SA: Itau BBA's Pedro Leduc rated Grupo Supervielle SA (SUPV) as Outperform with a price target of $15, with shares closing at $10.70.
Oscar Health Inc and BridgeBio Pharma Inc: Dean Sublett from Stephens & Co. rated Oscar Health Inc (OSCR) as Equal-Weight with a target of $17, and William Pickering from Bernstein rated BridgeBio Pharma Inc (BBIO) as Outperform with a target of $94, with respective closing prices of $15.59 and $72.70.

Real-time Intelligence: Benzinga Pro offers the fastest news alerts for traders to stay updated on market movements.
Exclusive Content: Subscribers gain access to unique stories and insights generated by Benzinga reporters.
Community of Traders: Over 10,000 serious traders are part of the Benzinga Pro community, enhancing their trading strategies.
Market Winning Tools: The platform provides essential tools and information to help traders succeed in the stock market.

Milei's Election Impact: Javier Milei's victory in Argentina's midterm elections has led to a significant surge in the country's stocks and bonds, reflecting increased investor confidence and a potential reduction in political risk.
Legislative Power and Reforms: With his coalition securing 41% of the vote, Milei is positioned to implement extensive libertarian reforms, including government spending cuts and tax system overhauls, bolstered by a substantial increase in congressional representation.
U.S. Support and Economic Outlook: The U.S. Treasury Secretary praised Milei's mandate as a success of U.S. policy in Latin America, highlighting the potential for increased private sector investment and economic freedom in Argentina.
Stock Market Reactions: Following the election results, several Argentine stocks listed in the U.S. experienced dramatic gains, with some rising over 34%, indicating strong market enthusiasm for Milei's economic agenda.
Sprott Gold Miners ETF Performance: The Sprott Gold Miners ETF is underperforming, down approximately 6.2% in Monday afternoon trading.
Weakest Components: Key contributors to the ETF's decline include Gold Fields Limited, which fell by about 8.9%, and Coeur Mining, which decreased by about 8.4%.
Market Context: The performance of the ETF is part of a broader market trend observed on Monday.
Author's Perspective: The views expressed in the article are those of the author and do not necessarily represent Nasdaq, Inc.

Avidity Biosciences Acquisition: Avidity Biosciences Inc. shares surged after Novartis AG announced its acquisition of the company for $72.00 per share, a 46% premium over Avidity's closing price on October 24.
Pre-Market Trading Highlights: Several stocks saw significant gains in pre-market trading, including Click Holdings Limited (+173%), Treasure Global Inc (+52.4%), and Banco BBVA Argentina SA (+31.3%).
Notable Stock Declines: Picard Medical, Inc. experienced a sharp decline of 65.3%, while Genenta Science SPA and Wellgistics Health Inc. also saw significant drops of 32.3% and 31.5%, respectively.
Market Overview: The article provides a snapshot of various stocks' performances in pre-market trading, highlighting both gainers and losers, along with their respective percentage changes.
ETF Performance: The Simplify Macro Strategy ETF is underperforming, down approximately 3.6% in Thursday afternoon trading.
Weakest Components: Key contributors to this decline include Civitas Resources, which fell by about 6.7%, and Chemours, which decreased by around 5.5%.






